Hisamitsu Pharmaceutical Ownership
HPX Stock | EUR 25.20 0.20 0.80% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Hisamitsu |
Hisamitsu Stock Ownership Analysis
About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hisamitsu Pharmaceutical last dividend was issued on the 27th of February 2023. The entity had 2:1 split on the 27th of June 2000. Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people. To learn more about Hisamitsu Pharmaceutical Co call Kazuhide Nakatomi at 81 3 5293 1720 or check out https://www.hisamitsu.co.jp.Hisamitsu Pharmaceutical Outstanding Bonds
Hisamitsu Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hisamitsu Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hisamitsu bonds can be classified according to their maturity, which is the date when Hisamitsu Pharmaceutical Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Currently Active Assets on Macroaxis
Other Information on Investing in Hisamitsu Stock
Hisamitsu Pharmaceutical financial ratios help investors to determine whether Hisamitsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hisamitsu with respect to the benefits of owning Hisamitsu Pharmaceutical security.